Development of a Novel Multi‐Epitope Vaccine Against Streptococcus anginosus Infection via Reverse Vaccinology Approach
Immunology · 2025-07 · 175 (3) · 339-358
DOI: 10.1111/imm.13936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, online erschienen am 23.04.2025. Verfasst von Linglan Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Institute of Pathogenic Biology, Hengyang Medical School, University of…. Hauptthemen laut MEDLINE: Streptococcal Infections, Streptococcus anginosus, Streptococcal Vaccines, Epitopes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Scientific Research Project of the Education Department of Hunan Province.
Abstract (Originalsprache)
Streptococcus anginosus is an opportunistic pathogen known for its capability to cause a broad range of infections, posing a significant and growing global health concern. Alongside enhancing diagnostic capabilities and bolstering public health initiatives, developing a safe and effective vaccine represents a promising strategy to tackle this health challenge. In this paper, we employed an array of bioinformatics tools to engineer a subunit vaccine that exhibits high immunogenicity against S. anginosus . After constructing the multi‐epitope vaccine, we subsequently predicted its secondary and tertiary protein structures. After refining and validating the modelled structure, we utilised advanced computational approaches, including molecular docking and dynamic simulations, to evaluate the binding affinity, compatibility, and stability of the vaccine–adjuvant complexes. Eventually, in silico cloning was conducted to optimise protein expression and production. The multi‐epitope subunit vaccine we developed showed properties in antigenicity and immunity theoretically. The computational study revealed that this vaccine demonstrates significant efficacy against S. anginosus .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Institute of Pathogenic Biology, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Department of Clinical Laboratory, Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, Hunan, China.
- Hunan Prevention and Treatment Institute for Occupational Diseases, Affiliated Prevention and Treatment Institute for Occupational Diseases of University of South China, Hengyang Medical School, University of South Chin…
- Tianjin Key Laboratory of Acute Abdomen Disease-Associated Organ Injury and ITCWM Repair, Institute of Integrative Medicine of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, Chin…
ORCID-Profile: Tian Li
Förderung
- Natural Science Foundation of Hunan Province
- Scientific Research Project of the Education Department of Hunan Province
Zitieren
APA
Xu, L., Xie, N., Liu, Y., Tang, H., Li, T., Peng, J., & Li, R. (2025). Development of a Novel Multi‐Epitope Vaccine Against Streptococcus anginosus Infection via Reverse Vaccinology Approach. Immunology, 175(3), 339-358. https://doi.org/10.1111/imm.13936
Vancouver
Xu L, Xie N, Liu Y, Tang H, Li T, Peng J, et al. Development of a Novel Multi‐Epitope Vaccine Against Streptococcus anginosus Infection via Reverse Vaccinology Approach. Immunology. 2025;175(3):339-358. doi:10.1111/imm.13936
BibTeX
@article{Xu2025,
author = {Xu, Linglan and Xie, Nan and Liu, Yiqing and Tang, Hongmei and Li, Tian and Peng, Jiaofeng and Li, Ranhui},
title = {Development of a Novel Multi‐Epitope Vaccine Against Streptococcus anginosus Infection via Reverse Vaccinology Approach},
journal = {Immunology},
year = {2025},
volume = {175},
number = {3},
pages = {339--358},
doi = {10.1111/imm.13936}
}
EUVIMED